These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35660541)

  • 21. Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub-Saharan Africa: a systematic review with meta-analysis and meta-regression.
    Mushi MF; Olum R; Bongomin F
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35781514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syngonanthus nitens Bong. (Rhul.)-Loaded Nanostructured System for Vulvovaginal Candidiasis Treatment.
    Dos Santos Ramos MA; de Toledo LG; Calixto GM; Bonifácio BV; de Freitas Araújo MG; Dos Santos LC; de Almeida MT; Chorilli M; Bauab TM
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern.
    Khaksar Baniasadi A; Ayatollahi Mosavi SA; Sharifi I; Bamorovat M; Salari S; Ahmadi A; Amanizadeh A; Agha Kuchak Afshari S
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3292-3303. PubMed ID: 36184563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spilanthol as a promising antifungal alkylamide for the treatment of vulvovaginal candidiasis.
    Fabri RL; Freitas JCO; Lemos ASO; Campos LM; Diniz IOM; Pinto NCC; Silva TP; Palazzi C; Marchesini P; Monteiro C; Barbosa AF; Carvalho MG; Chedier LM; Araújo MGF; Apolônio ACM; Rocha VN; Melo RCN; Pinto PF
    Med Mycol; 2021 Dec; 59(12):1210-1224. PubMed ID: 34468763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis.
    Shi Y; Zhu Y; Fan S; Liu X; Liang Y; Shan Y
    BMC Infect Dis; 2020 Apr; 20(1):287. PubMed ID: 32393342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
    de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
    Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pulsatilla decoction inhibits vulvovaginal Candida albicans proliferation and reduces inflammatory cytokine levels in vulvovaginal candidiasis mice].
    Xia D; Zhang M; Shi G; Xu Z; Wu D; Shao J; Wang T; Wang C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):153-7. PubMed ID: 26927371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal effect of hydroethanolic extract of Fridericia chica (Bonpl.) L. G. Lohmann leaves and its therapeutic use in a vulvovaginal candidosis model.
    Lima WG; Araújo MGF; Brito JCM; Castilho RO; Cardoso VN; Fernandes SOA
    J Mycol Med; 2022 Aug; 32(3):101255. PubMed ID: 35219909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vulvovaginal candidiasis and asymptomatic vaginal colonization in Portugal: Epidemiology, risk factors and antifungal pattern.
    Fernandes Â; Azevedo N; Valente A; Dias M; Gomes A; Nogueira-Silva C; Henriques M; Silva S; Gonçalves B
    Med Mycol; 2022 May; 60(5):. PubMed ID: 35482711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Evaluation of Microencapsulated Oregano Essential Oil as an Alternative Treatment for
    Fernandes L; Barco-Tejada A; Blázquez E; Araújo D; Ribeiro A; Silva S; Cussó L; Costa-de-Oliveira S; Rodrigues ME; Henriques M
    ACS Appl Mater Interfaces; 2024 Aug; 16(31):40628-40640. PubMed ID: 39067028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biased Genotype Distributions of Candida albicans Strains Associated with 649 Clinical Vulvovaginal Candidiasis in China.
    Pang Q; Liu W; Cui F; Kan S; Li X
    Mycopathologia; 2022 Dec; 187(5-6):427-437. PubMed ID: 36209322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
    de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
    J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The liquid Kangfuxin (KFX) has efficient antifungal activity and can be used in the treatment of vulvovaginal candidiasis in mice.
    Ma J; Yang YC; Su LQ; Qin DM; Yuan K; Zhang Y; Wang RR
    Lett Appl Microbiol; 2022 Apr; 74(4):564-576. PubMed ID: 34958703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mrr2 mutations and upregulation are associated with increased fluconazole resistance in Candida albicans isolates from patients with vulvovaginal candidiasis.
    Feng W; Yang J; Ji Y; Xi Z; Yang L; Zhu X; Ma Y
    Lett Appl Microbiol; 2020 Feb; 70(2):95-101. PubMed ID: 31705810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
    Zhang X; Li T; Chen X; Wang S; Liu Z
    BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaginal homeostasis features of Vulvovaginal Candidiasis through vaginal metabolic profiling.
    Chen X; Wang J; Chen J; Wang G; Zhang R; Qiu J
    Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37573133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clotrimazole-loaded N-(2-hydroxy)-propyl-3-trimethylammonium, O-palmitoyl chitosan nanoparticles for topical treatment of vulvovaginal candidiasis.
    Facchinatto WM; Galante J; Mesquita L; Silva DS; Martins Dos Santos D; Moraes TB; Campana-Filho SP; Colnago LA; Sarmento B; das Neves J
    Acta Biomater; 2021 Apr; 125():312-321. PubMed ID: 33639312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low intensity ultrasound-mediated drug-loaded nanoparticles intravaginal drug delivery: an effective synergistic therapy scheme for treatment of vulvovaginal candidiasis.
    Yang M; Cao Y; Zhang Z; Guo J; Hu C; Wang Z; Du Y
    J Nanobiotechnology; 2023 Feb; 21(1):53. PubMed ID: 36782198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.
    Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
    Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against
    Tian B; Yan Q; Wang J; Ding C; Sai S
    Int J Nanomedicine; 2017; 12():7131-7141. PubMed ID: 29026306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.